SS Innovations International, Inc. has achieved a significant milestone in the field of surgical robotics. The company announced the successful completion of the world's first robotic telesurgery for weight loss using its advanced SSI Mantra 3 surgical robotic system. Led by Dr. Mohit Bhandari, a pioneer in bariatric surgery, the surgery was remotely performed at a distance of 560 miles and executed on-site at the Mohak Bariatric & Robotic Surgery Centre in Indore, India.
The telesurgery involved two advanced one-anastomosis gastric bypass (OAGB) procedures, which were performed with zero perceptible lag, flawless precision, and seamless robotic control using the SSI Mantra 3 system. Despite the vast distance, the surgery set a new global benchmark for remote surgery capabilities and demonstrated the immense potential of robotic telesurgery.
Dr. Sudhir Srivastava, Chairman of the Board and Chief Executive Officer of SS Innovations, emphasized the significance of this achievement, stating that the company views it as a defining moment for the future of global healthcare. He highlighted that robotic telesurgery powered by SSI Mantra is bridging healthcare gaps and ensuring that world-class surgical expertise reaches even the most remote regions, eliminating the need for patients to travel and making advanced surgical care truly accessible and affordable.
Notably, the company's focus on practical solutions that enhance surgical efficiency, democratize access to specialized care, and improve patient outcomes across India and beyond is evident in its commitment to revolutionizing surgical care through cutting-edge technology and a strong humanitarian vision.
The successful completion of the world's first robotic telesurgery for weight loss represents a bold new paradigm for access, equity, and excellence in healthcare and underscores SS Innovations' leadership in developing innovative surgical robotic technologies.
As SS Innovations continues to refine its technology, its vision to make the benefits of robotic surgery affordable and accessible to a larger segment of the global population remains a driving force behind its groundbreaking achievements in the field of surgical robotics. Following these announcements, the company's shares moved -1.66%, and are now trading at a price of $4.73. Check out the company's full 8-K submission here.